Polyethylene Glycol
NDC 68001-505, Polyethylene Glycol, powder, for suspension, from BluePoint Laboratories.
- Product NDC
- 68001-505
- Status
- Listed
- Labeler
- BluePoint Laboratories
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA091077
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68001-505 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- POLYETHYLENE GLYCOL 335017 g/17g
Pharmacologic classes
Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68001-505-55 | 68001050555 | 238 g in 1 BOTTLE (68001-505-55) |
| 68001-505-69 | 68001050569 | 510 g in 1 BOTTLE (68001-505-69) |
Linked data
RxNorm, label and prices
Related lookups
NADAC price for package 68001050555
GET /v1/drugs/nadac/68001050555NADAC price for package 68001050569
GET /v1/drugs/nadac/68001050569
Use it
Look up 68001-505 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68001-505 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68001-505. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.